Department of Developmental Neurology, University Children's Hospital, Tübingen, Germany.
Dev Med Child Neurol. 2012 Oct;54(10):892-7. doi: 10.1111/j.1469-8749.2012.04377.x. Epub 2012 Aug 9.
A substantial proportion of patients with neurofibromatosis type 1 (NF1) have attention-deficit disorder with or without hyperactivity (AD[H]D). This study explored the influence of AD(H)D symptoms on the intellectual profile of patients with NF1.
We retrospectively analysed neuropsychological data from 114 children (66 males, 48 females; age range 6-16y; mean age 9y 3mo [SE 3mo]) with NF1 from an NF1 outpatients department. Assessment included psychiatric diagnosis of AD(H)D (DSM-IV-TR criteria) and intelligence testing (Wechsler Intelligence Scale for Children, German version). Magnetic resonance images were available for all patients, intracranial findings being an exclusion criterion. The effects of AD(H)D symptoms on intelligence and on the cognitive profile were tested by analyses of variance.
Patients with AD(H)D symptoms performed significantly worse than those without AD(H)D symptoms on all intelligence measures (main effects for Full-scale, Verbal, and Performance IQ; p<0.005). Subtests typically impaired in patients with NF1 (visuospatial skills and arithmetic) were not specifically influenced by AD(H)D symptoms. There were no differences between AD(H)D subtypes.
AD(H)D symptoms have a negative impact on the intellectual development of children with NF1. This impact seems to be of an unspecific nature, with a general attenuation of the cognitive profile.
相当一部分 1 型神经纤维瘤病(NF1)患者存在注意缺陷多动障碍(AD[H]D)或不伴多动(AD[H]D)。本研究探讨了 AD(H)D 症状对 NF1 患者智力特征的影响。
我们回顾性分析了来自 NF1 门诊的 114 名 NF1 患儿(66 名男性,48 名女性;年龄 6-16 岁;平均年龄 9 岁 3 个月[SE 3 个月])的神经心理学数据。评估包括 AD(H)D 的精神病学诊断(DSM-IV-TR 标准)和智力测试(德国韦氏儿童智力量表)。所有患者均有磁共振成像(MRI),颅内发现为排除标准。通过方差分析测试 AD(H)D 症状对智力和认知特征的影响。
AD(H)D 症状组患儿在所有智力测试(全量表、言语和操作智商的主效应;p<0.005)中的表现均明显差于无 AD(H)D 症状组患儿。在 NF1 患者中受损的典型亚测试(视觉空间技能和算术)不受 AD(H)D 症状的影响。AD(H)D 亚型之间无差异。
AD(H)D 症状对 NF1 患儿的智力发育有负面影响。这种影响似乎具有非特异性,认知特征普遍减弱。